ArticleNPJ precision oncology2026

Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology.

Marlinde C Schoonbeek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.